Ottawa, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The global drugs market size was valued at USD 1592.58 billion in 2024 and is predicted to hit around USD 2895.42 billion by 2034, rising at a 6.04% CAGR, a study published by Towards Healthcare a sister firm of …

ESPN’s "College GameDay" featured the incredible story of Auburn kicker Alex McPherson on Saturday morning.  The feature began by highlighting McPherson’s mental toughness, which he said is paramount for a kicker to possess, and prepared him for …

Medications for Crohn’s disease can reduce inflammation, ease Crohn’s symptoms, and prevent flares, but some come with side effects that can be difficult to handle. There are several types of Crohn’s medications, such as 5-aminosalicylates (5-ASAs), …

In a new study, artificial intelligence matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn's disease patients. The results, published in Clinical Gastroenterology and …

Emmerdale has established itself as one of Britain's most beloved soaps; however, numerous cherished cast members have encountered devastating health battles. Since the ITV drama first aired in 1972, it has delivered viewers endless unforgettable …

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered why smoking tobacco helps people suffering from ulcerative colitis, a chronic disease typified by inflammation of the large intestine. …

Strategic manufacturing partner’s expertise instrumental in bringing first-of-its-kind rheumatoid arthritis treatment to market MISSISSAUGA, ONTARIO, CANADA, September 17, 2025 /⁨EINPresswire.com⁩/ -- Kingstec Technologies, a leader in project …

The research group led by Drs. Mitsuru Arase, Mari Murakami, and Prof. Kiyoshi Takeda (Graduate School of Medicine/ Immunology Frontier Research Center at The University of Osaka) revealed that transcription factors RUNX2 and BHLHE40 play crucial roles …

Newswise — In a new study, artificial intelligence matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology …

The Crohn's disease pipeline includes several drugs in mid- and late-stage development, poised for approval in the near future in both adults and pediatrics. The emerging landscape holds a diverse range of therapeutic alternatives for treatment, …